Nisa Investment Advisors LLC Sells 7,108 Shares of HCA Healthcare, Inc. $HCA

Nisa Investment Advisors LLC decreased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 10.8% in the third quarter, Holdings Channel.com reports. The institutional investor owned 58,454 shares of the company’s stock after selling 7,108 shares during the period. Nisa Investment Advisors LLC’s holdings in HCA Healthcare were worth $24,913,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Kingswood Wealth Advisors LLC raised its stake in HCA Healthcare by 63.0% during the 3rd quarter. Kingswood Wealth Advisors LLC now owns 4,882 shares of the company’s stock valued at $2,081,000 after buying an additional 1,887 shares during the last quarter. Strategic Planning Group LLC lifted its holdings in HCA Healthcare by 47.8% in the third quarter. Strategic Planning Group LLC now owns 21,165 shares of the company’s stock valued at $9,021,000 after acquiring an additional 6,848 shares during the period. Benjamin Edwards Inc. grew its stake in shares of HCA Healthcare by 76.7% during the 3rd quarter. Benjamin Edwards Inc. now owns 1,283 shares of the company’s stock valued at $547,000 after purchasing an additional 557 shares during the period. HB Wealth Management LLC boosted its holdings in shares of HCA Healthcare by 30.4% in the third quarter. HB Wealth Management LLC now owns 6,876 shares of the company’s stock worth $2,931,000 after buying an additional 1,601 shares during the last quarter. Finally, Caldwell Trust Co increased its holdings in HCA Healthcare by 5.0% during the third quarter. Caldwell Trust Co now owns 1,311 shares of the company’s stock valued at $559,000 after buying an additional 63 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insiders Place Their Bets

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 1.30% of the stock is owned by insiders.

Analyst Ratings Changes

HCA has been the topic of a number of recent research reports. Bank of America raised their target price on HCA Healthcare from $430.00 to $470.00 and gave the stock a “neutral” rating in a report on Monday, October 27th. Stephens lifted their price objective on HCA Healthcare from $450.00 to $500.00 and gave the company an “overweight” rating in a research report on Monday, October 27th. Royal Bank Of Canada raised their target price on shares of HCA Healthcare from $482.00 to $525.00 and gave the stock an “outperform” rating in a research note on Friday, December 19th. UBS Group increased their price objective on shares of HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Finally, The Goldman Sachs Group upped their target price on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Fourteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $485.95.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA is among the first health systems to access OpenAI’s new healthcare programs — a move that could drive clinical efficiency, faster workflow automation and potential cost savings if deployed broadly across HCA’s network. HCA Healthcare among first to access OpenAI’s new health care programs
• Positive Sentiment: OpenAI launched ChatGPT for Healthcare at several large systems — broader industry adoption reduces implementation risk and can accelerate HCA’s rollout benefits (clinical decision support, patient triage, revenue-cycle automation). OpenAI launches ChatGPT for Healthcare at several large health systems
• Positive Sentiment: HCA and AdventHealth are expanding ER footprints in Florida — inorganic/greenfield capacity additions should help volume growth and market share in a high-margin service line. HCA, AdventHealth expand Florida ER footprints
• Positive Sentiment: A new emergency facility opened in Arlington — incremental capacity and local access that can lift admissions and outpatient revenues. New emergency health facility opens in Arlington
• Positive Sentiment: HCA Florida Capital Hospital and UCF launched a medical residency program — strengthens physician pipeline and could reduce staffing pressures/costs over time. HCA Florida Capital Hospital, UCF create new medical residency program
• Positive Sentiment: An analyst raised HCA’s price target to $520 — a bullish signal that supports upside in the medium term if execution and margins track. HCA Healthcare (NYSE:HCA) Price Target Raised to $520.00
• Neutral Sentiment: HCA Georgia hospital named a new CFO — routine executive hire that supports local operations but is not material company‑wide. HCA Georgia hospital taps CFO
• Neutral Sentiment: HCA rolled out a “Talk to a nurse for free” service — positive PR and access initiative but limited immediate financial impact. HCA says: ‘Talk to a nurse for free’
• Negative Sentiment: CEO exit after nine months at an HCA Virginia behavioral health hospital — leadership turnover can signal integration or operational issues in a growing behavioral-health segment. HCA Virginia behavioral health hospital CEO exits after 9 months
• Negative Sentiment: A MarketWatch note flagged HCA’s relative underperformance versus peers on a recent trading day — highlights near‑term downside risk if investors rotate into other healthcare names. HCA Healthcare Inc. stock underperforms Thursday when compared to competitors despite daily gains

HCA Healthcare Stock Down 1.4%

Shares of HCA stock opened at $472.40 on Friday. The stock has a market cap of $107.80 billion, a P/E ratio of 18.26, a PEG ratio of 1.32 and a beta of 1.36. The company’s fifty day simple moving average is $479.87 and its two-hundred day simple moving average is $427.05. HCA Healthcare, Inc. has a 52 week low of $295.00 and a 52 week high of $520.00.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The company had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the previous year, the business earned $4.90 earnings per share. The firm’s revenue for the quarter was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, analysts anticipate that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were issued a $0.72 dividend. The ex-dividend date of this dividend was Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is presently 11.13%.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.